Intensive multifactorial intervention improved renal impairment in short-duration type 2 diabetes: A randomized, controlled, 7-year follow-up trial

J Diabetes Complications. 2020 Jan;34(1):107468. doi: 10.1016/j.jdiacomp.2019.107468. Epub 2019 Nov 14.

Abstract

Aims: To investigate the effect of multifactorial intervention on the urinary albumin to creatinine ratio (UACR) and the estimated glomerular filtration rate (eGFR) in short-duration type 2 diabetes.

Methods: A total of 150 type 2 diabetes patients, with disease duration <1 year and with no evidence of atherosclerosis were randomized to either the intensive intervention group (IG, n = 75), or the conventional group (CG, n = 75) for 7 years. The predefined endpoint of microvascular complications was the progression of renal impairments (the development of albuminuria and the change of eGFR).

Results: The incidence of progression to albuminuria (UACR ≥30 mg/g) was 12% in IG and 28% in CG (HR 0.37, 95% CI: 0.19-0.70, P = .0025). eGFR was significantly lower in IG than that in CG in the year 2 (P = .043) and 3 (P = .032) follow-up. Sex, fasting plasma glucose (FPG), HbA1c, and systolic blood pressure (SBP) were independently associated with the UACR (β = -5.112, P = .015; β = 0.908, P = .045; β = 2.087, P = .038; and β = 2.787, P = .002, respectively); aging was independently associated with eGFR (β = -0.447, P = .000).

Conclusions: Intensive multifactorial intervention delayed the progression to albuminuria, and reduced eGFR rapidly in early stage of intervention in short-duration type 2 diabetes. FPG, HbA1c, and SBP were risk factors for UACR increase; aging was a risk factor for eGFR decline.

Keywords: Diabetes complications; Estimated glomerular filtration rate; Multifactorial intervention; Type 2 diabetes; Urinary albumin to creatinine ratio.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Albuminuria / etiology
  • Albuminuria / pathology
  • Albuminuria / therapy*
  • Antihypertensive Agents / administration & dosage
  • Combined Modality Therapy / methods
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / pathology
  • Diabetes Mellitus, Type 2 / therapy*
  • Diabetic Nephropathies / pathology
  • Diabetic Nephropathies / therapy*
  • Diet Therapy
  • Disease Progression
  • Drug Therapy, Combination / methods
  • Exercise Therapy
  • Female
  • Follow-Up Studies
  • Glomerular Filtration Rate
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypolipidemic Agents / administration & dosage
  • Male
  • Middle Aged
  • Patient Education as Topic
  • Renal Insufficiency / etiology
  • Renal Insufficiency / pathology
  • Renal Insufficiency / therapy
  • Risk Reduction Behavior
  • Time Factors

Substances

  • Antihypertensive Agents
  • Hypoglycemic Agents
  • Hypolipidemic Agents